Spirocycles
First Claim
Patent Images
1. A compound of the (general) structural formula:
- ##STR29## or a pharmaceutically acceptable salt, hydrate or crystal form thereof, wherein;
X is O, S, or CH2Y is C or O with the proviso that;
If Y=O, than R5 and R6 are nothingIf Y=O, than X=CH2If X=O or S, than Y=CR1 is H3 CSO2 NH--, H3 CO--, C1-6 AlkylSO2 --, C1-6 AlkylCONH-- or NO2 --;
R2 is --H, --OCH3 or C1-6 Alkyl;
R3 and R4 taken together are=O, or R3 is H and R4 is one of the following --OH, --NHCOCH3, --NHCOCH3 SO2 Phenyl, --NHCOCH3 SO2 C1-6 Alkyl, NHCOCH2 SPhenyl, NHCOCH2 S C1-6 Alkyl, --NHCOC(CH3)2 OH or NHSO2 C1-6 Alkyl;
or R3=R4=HR5 and R6 are independently H, C1-C6 Alkyl(, or when taken together are --(CH2)n --, where n=2-5);
or =CH2 ;
R7 is selected from ##STR30## And R8 is H, --CH3, --OH, --CN, --O--C1-C6-alkyl, --NHCO C1-6 Alkyl, --NHSO2 C1-6 Alkyl, --SO2 C1-6 Alkyl are Class III antiarrhythmic agents.
1 Assignment
0 Petitions
Accused Products
Abstract
Compounds of the general formula: ##STR1## or a pharmaceutically acceptable salt, hydrate or crystal form enantiomer, diastereomer or mixtures thereof are Class III antiarrhythmic agents.
32 Citations
11 Claims
-
1. A compound of the (general) structural formula:
- ##STR29## or a pharmaceutically acceptable salt, hydrate or crystal form thereof, wherein;
X is O, S, or CH2 Y is C or O with the proviso that; If Y=O, than R5 and R6 are nothing If Y=O, than X=CH2 If X=O or S, than Y=C R1 is H3 CSO2 NH--, H3 CO--, C1-6 AlkylSO2 --, C1-6 AlkylCONH-- or NO2 --; R2 is --H, --OCH3 or C1-6 Alkyl; R3 and R4 taken together are=O, or R3 is H and R4 is one of the following --OH, --NHCOCH3, --NHCOCH3 SO2 Phenyl, --NHCOCH3 SO2 C1-6 Alkyl, NHCOCH2 SPhenyl, NHCOCH2 S C1-6 Alkyl, --NHCOC(CH3)2 OH or NHSO2 C1-6 Alkyl;
or R3=R4=HR5 and R6 are independently H, C1-C6 Alkyl(, or when taken together are --(CH2)n --, where n=2-5);
or =CH2 ;R7 is selected from ##STR30## And R8 is H, --CH3, --OH, --CN, --O--C1-C6-alkyl, --NHCO C1-6 Alkyl, --NHSO2 C1-6 Alkyl, --SO2 C1-6 Alkyl are Class III antiarrhythmic agents. - View Dependent Claims (4, 5, 6, 7, 8, 9, 10, 11)
- ##STR29## or a pharmaceutically acceptable salt, hydrate or crystal form thereof, wherein;
-
2. Compounds of the (general) structural formula:
- ##STR31## or a pharmaceutically acceptable salt, hydrate or crystal form thereof, wherein;
X is O, S, or CH2 Y is C or O with the proviso that; If Y=O, than R5 and R6 are nothing If Y=O, than X=CH2 If X=O or S, than Y=C R1 is H3 CSO2 NH--, H3 CO--, C1-6 AlkylSO2 --, C1-6 AlkylCONH-- or NO2 --; R2 is --H, --OCH3 or C1-6 Alkyl; R3 and R4 taken together are=O, or R3 is H and R4 is one of the following --OH, --NHCOCH3, --NHCOCH3 SO2 Phenyl, --NHCOCH3 SO2 C1-6 Alkyl, NHCOCH2 SPhenyl, NHCOCH2 S C1-6 Alkyl, --NHCOC(CH3)2 OH or NHSO2 C1-6 Alkyl;
or R3=R4=HR5 and R6 are independently H, C1-C6 Alkyl(, or when taken together are --(CH2)n --,where n=2-5);
or =CH2 ;R7 is selected from ##STR32## And R8 is H, --CH3, --OH, --CN, --O--C1-C6-alkly, --NHCO C1-6 Alkyl, --NHSO2 C1-6 Alkyl, --SO2 C1-6 Alkyl are class III antiarrhythmic agents.
- ##STR31## or a pharmaceutically acceptable salt, hydrate or crystal form thereof, wherein;
-
3. A compound selected from the group consisting of N-[4'"'"'-(3,4-dihydro-2 (1H )-isoquinolinyl)-3,4-dihydro-4-oxospiro[2H-1-benzopyran-2,1 '"'"'-cyclohexan]-6-yl]methanesulfonamide alpha and beta isomers ##STR33## or pharmaceutically acceptable salts, hydrates and crystal forms thereof.
Specification